Li Wei

6.2k total citations
157 papers, 3.5k citations indexed

About

Li Wei is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Epidemiology. According to data from OpenAlex, Li Wei has authored 157 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 21 papers in Geriatrics and Gerontology and 21 papers in Epidemiology. Recurrent topics in Li Wei's work include Pharmaceutical Practices and Patient Outcomes (18 papers), Blood Pressure and Hypertension Studies (14 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Li Wei is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (18 papers), Blood Pressure and Hypertension Studies (14 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Li Wei collaborates with scholars based in United Kingdom, China and Hong Kong. Li Wei's co-authors include Ian Chi Kei Wong, Wallis C. Y. Lau, Thomas M. MacDonald, D. A. Grubb, C Bolton-Smith, J. A. Simpson, L. F. Masson, Geraldine McNeill, Ruth Brauer and Kenneth K. C. Man and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Li Wei

151 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Wei United Kingdom 31 614 531 440 387 369 157 3.5k
Mitchell Levine Canada 33 549 0.9× 424 0.8× 293 0.7× 247 0.6× 528 1.4× 161 4.2k
Yu Guo China 36 685 1.1× 943 1.8× 440 1.0× 801 2.1× 861 2.3× 174 4.7k
Elizabeth D. Kantor United States 23 225 0.4× 598 1.1× 272 0.6× 212 0.5× 498 1.3× 55 2.8k
Anne Elise Eggen Norway 29 547 0.9× 606 1.1× 167 0.4× 225 0.6× 414 1.1× 96 2.9k
Tomasz Zdrojewski Poland 32 1.2k 2.0× 871 1.6× 257 0.6× 435 1.1× 534 1.4× 267 3.6k
Yao He China 33 552 0.9× 704 1.3× 376 0.9× 594 1.5× 977 2.6× 254 3.9k
Giovannella Baggio Italy 37 687 1.1× 405 0.8× 455 1.0× 339 0.9× 905 2.5× 108 4.1k
Talicia Tarver United States 7 1.6k 2.6× 357 0.7× 449 1.0× 660 1.7× 334 0.9× 21 4.5k
Angela Marie Abbatecola Italy 38 459 0.7× 459 0.9× 617 1.4× 406 1.0× 1.4k 3.8× 95 4.0k
Kathleen A. Lane United States 40 660 1.1× 288 0.5× 215 0.5× 421 1.1× 532 1.4× 124 4.4k

Countries citing papers authored by Li Wei

Since Specialization
Citations

This map shows the geographic impact of Li Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Wei more than expected).

Fields of papers citing papers by Li Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Wei. The network helps show where Li Wei may publish in the future.

Co-authorship network of co-authors of Li Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Li Wei. A scholar is included among the top collaborators of Li Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Wei. Li Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yan, Vincent Ka Chun, Chengsheng Ju, Thomas M. MacDonald, et al.. (2025). Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study. PubMed. 4(1). e000857–e000857.
4.
Wei, Li, Haibo Gao, Xuemei Zhao, et al.. (2024). Associations of Heart Failure Onset Age with All-Cause Mortality: The Kailuan Study. SHILAP Revista de lepidopterología. 9(1).
6.
Mackenzie, Isla S., C J Hawkey, Ian Ford, et al.. (2024). Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation. Health Technology Assessment. 28(18). 1–55. 2 indexed citations
7.
Zhang, Qianqian, Jiuru Zhao, Li Wei, et al.. (2023). Relationship Between Birth Weight and Asthma Diagnosis: A Cross-Sectional Survey Study Based on the National Survey of Children’s Health in the U.S.. BMJ Open. 13(12). e076884–e076884. 1 indexed citations
8.
Lau, Wallis C. Y., et al.. (2023). Effectiveness of Facebook Groups and Pages on Participant Recruitment Into a Randomized Controlled Trial During the COVID-19 Pandemic: Descriptive Study. Journal of Medical Internet Research. 25. e46190–e46190. 4 indexed citations
9.
Chan, Adrienne Y L, Daniel Hsiang‐Te Tsai, Wallis C. Y. Lau, et al.. (2023). Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study. Nature Communications. 14(1). 5005–5005. 29 indexed citations
10.
Chan, Adrienne Y L, Tiantian Ma, Wallis C. Y. Lau, et al.. (2023). Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study. EClinicalMedicine. 58. 101780–101780. 34 indexed citations
11.
Blais, Joseph E., Yue Wei, Hassan Alwafi, et al.. (2021). Trends in lipid-modifying agent use in 83 countries. Atherosclerosis. 328. 44–51. 70 indexed citations
12.
Ma, Tiantian, Ian Chi Kei Wong, Cate Whittlesea, et al.. (2020). Initial cardiovascular treatment patterns during the first 90 days following an incident cardiovascular event. British Journal of Clinical Pharmacology. 87(3). 1043–1055. 5 indexed citations
13.
Zhao, Hou-Yu, Li Wei, Lin Zhuo, et al.. (2020). Validation of an algorithm to evaluate the appropriateness of outpatient antibiotic prescribing using big data of Chinese diagnosis text. BMJ Open. 10(3). e031191–e031191. 13 indexed citations
15.
Mackenzie, Isla S., S. V. Morant, Li Wei, Alastair M. Thompson, & Thomas M. MacDonald. (2016). Spironolactone use and risk of incident cancers: a retrospective, matched cohort study. British Journal of Clinical Pharmacology. 83(3). 653–663. 41 indexed citations
16.
Blandford, Ann, Dominic Furniss, Imogen Lyons, et al.. (2016). Exploring the Current Landscape of Intravenous Infusion Practices and Errors (ECLIPSE): protocol for a mixed-methods observational study. BMJ Open. 6(3). e009777–e009777. 27 indexed citations
17.
Wei, Li. (2012). Efficacy and Safety of Benbromarne and Allopurinol for Primary Gout ULT:A Meta-Analysis. Zhongguo xunzheng yixue zazhi. 2 indexed citations
18.
Austin, Harland, Li Wei, Bernard Lassègue, et al.. (2012). Angiotensin Receptor Type 1 Single Nucleotide Polymorphism 1166A/C is Associated With Malignant Arrhythmias and Altered Circulating miR-155 Levels in Patients With Chronic Heart Failure. Journal of Cardiac Failure. 18(9). 717–723. 24 indexed citations
19.
Cook, Vivian & Li Wei. (2011). Contemporary applied linguistics. Continuum eBooks. 11 indexed citations
20.
Wei, Li. (2009). Research on the effects of rehabilitation exercises on physical fitness of elder patients with type 2-diabetes mellitus. Zhongguo kangfu yixue zazhi. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026